/

Mineralys Therapeutics

Develops targeted medicines for aldosterone-driven cardiorenal diseases.

BiotechnologyPharmaceuticals mineralystx.com ↗

Company facts

Founded: 2019
Employees: 51
Headquarters: United States
Type: Public
Listed: NASDAQ: MLYS